Maartens G - Search Results

1

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.

Ismail NA, Omar SV, Moultrie H, Bhyat Z, Conradie F, Enwerem M, Ferreira H, Hughes J, Joseph L, Kock Y, Letsaolo V, Maartens G, Meintjes G, Ngcamu D, Okozi N, Padanilam X, Reuter A, Romero R, Schaaf S, Te Riele J, Variava E, van der Meulen M, Ismail F, Ndjeka N. Ismail NA, et al. Among authors: maartens g. Lancet Infect Dis. 2022 Apr;22(4):496-506. doi: 10.1016/S1473-3099(21)00470-9. Epub 2021 Nov 12. Lancet Infect Dis. 2022. PMID: 34780706

2

Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis.

Bekker LG, Maartens G, Steyn L, Kaplan G. Bekker LG, et al. Among authors: maartens g. J Infect Dis. 1998 Aug;178(2):580-4. doi: 10.1086/517479. J Infect Dis. 1998. PMID: 9697749

3

Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosis.

Bekker LG, Haslett P, Maartens G, Steyn L, Kaplan G. Bekker LG, et al. Among authors: maartens g. J Infect Dis. 2000 Mar;181(3):954-65. doi: 10.1086/315328. J Infect Dis. 2000. PMID: 10720518 Clinical Trial.

4

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.

Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G. Schaars CF, et al. Among authors: maartens g. BMC Infect Dis. 2006 Jul 18;6:118. doi: 10.1186/1471-2334-6-118. BMC Infect Dis. 2006. PMID: 16846523 Free PMC article.

5

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection.

Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ. Rangaka MX, et al. Among authors: maartens g. Am J Respir Crit Care Med. 2007 Mar 1;175(5):514-20. doi: 10.1164/rccm.200610-1439OC. Epub 2006 Dec 7. Am J Respir Crit Care Med. 2007. PMID: 17158278 Free article.

6

Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.

Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ. Rangaka MX, et al. Among authors: maartens g. Clin Infect Dis. 2007 Jun 15;44(12):1639-46. doi: 10.1086/518234. Epub 2007 May 10. Clin Infect Dis. 2007. PMID: 17516410

7

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

McIlleron H, Meintjes G, Burman WJ, Maartens G. McIlleron H, et al. Among authors: maartens g. J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75. doi: 10.1086/518655. J Infect Dis. 2007. PMID: 17624828 Review.

8

Tuberculosis.

Maartens G, Wilkinson RJ. Maartens G, et al. Lancet. 2007 Dec 15;370(9604):2030-43. doi: 10.1016/S0140-6736(07)61262-8. Lancet. 2007. PMID: 17719083 Review.

9

Is it safe to switch between efavirenz and nevirapine in the event of toxicity?

Mehta U, Maartens G. Mehta U, et al. Among authors: maartens g. Lancet Infect Dis. 2007 Nov;7(11):733-8. doi: 10.1016/S1473-3099(07)70262-1. Lancet Infect Dis. 2007. PMID: 17961859 Review.

10

Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis.

Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Ren Y, et al. Among authors: maartens g. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):566-9. doi: 10.1097/QAI.0b013e3181642257. J Acquir Immune Defic Syndr. 2008. PMID: 18197120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page